Pharma

Your Article Summary

See Latest Articles

Anti-Malignancy Agent Avastin: Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer
Chugai Pharmaceutical Co., 11/10/09

Chugai Pharmaceutical Co., Ltd. announced that it obtained approval by the Ministry of Health, Labour and Welfare on 6 November for the additional indication of "Unresectable advanced or recurrent non–squamous non–small cell lung cancer" of its anti–VEGF human monoclonal antibody bevacizumab.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

 See all of Drug/Product Approvals